Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Chen, Jianying ^a   Liu, Zhenjun ^a   Hong, Mian Ming ^a   Zhang, Hongzhe ^a   Chen, Can ^a   Xiao, Mengyuan ^a   Wang, Junxian ^a   Yao, Feng ^a   Ba, Mingchuan ^a   Liu, Jinghu ^a   Guo, Zi Kuan ^b   Zhong, Jixin ^a,c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ANGIOGENIN; ANGIOPOIETIN RECEPTOR; BETA1 INTEGRIN; CD31 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; HERMES ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; UROKINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; CCL2 PROTEIN, HUMAN; CYTOKINE; PANCREATIC RIBONUCLEASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CELL VACUOLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROVESICLE; UMBILICAL CORD; ANALYSIS OF VARIANCE; CYTOLOGY; HYPOXIA; MESENCHYMAL STROMA CELL; METABOLISM; MICROVASCULATURE; PATHOPHYSIOLOGY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CHEMOKINE CCL2; CYTOKINES; HUMANS; HYPOXIA; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; RIBONUCLEASE, PANCREATIC; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84918536001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115316     Document Type: Article

References (28)

1. Da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 119: 2204-2213.
2. Wollert KC, Drexler H (2010) Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 7: 204-15.
3. Richardson JD, Nelson AJ, Zannettino AC, Gronthos S, Worthley SG, et al. (2013) Optimization of the Cardiovascular Therapeutic Properties of Mesenchymal Stromal/Stem Cells-Taking the Next Step. Stem Cell Rev 9: 281-302.
4. Liang X, Ding Y, Zhang Y, Tse HF, Lian Q (2014) Paracrine mechanisms of Mesenchymal Stem cell-based therapy: Current status and perspectives. Cell Transplant 23(9): 1045-59.
5. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, et al. (2011) Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30: 95-102.
6. Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3: 359.
7. Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, et al. (2012) Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 21: 3289-3297.
8. Mantel PY, Hoang AN, Goldowitz I, Potashnikova D, Hamza B, et al. (2013) Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe 13(5): 521-34.
9. Lau CS, Wong DT (2012) Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 7(3): e33037.
10. Hoffman EA, Perkumas KM, Highstrom LM, Stamer WD (2009) Regulation of myocilin-associated exosome release from human trabecular meshwork cells. Invest Ophthalmol Vis Sci 50(3): 1313-1318.
11. Lai RC, Yeo RW, Tan KH, Lim SK (2013) Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med 8: 197-209.
12. Dvorak HF, Brown LF, Detmar M, Dvovorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, an angiogenesis. Am J Pathol 146: 1029-1039.
13. Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: moving target for therapeutic intervention. J Clin Invest 103: 1237-1241.
14. Saharinen P, Bry M, Alitalo K (2010) How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17: 198-205.
15. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, et al. (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680.
16. Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, et al. (2007) Activation of plasminogen into plasmin at the surface of endothelial microparticles: A mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 110: 2432-2439.
17. Kurz H (2000) Physiology of angiogenesis. J Neurooncol 50: 17-35.
18. Liu CH, Hwang SM (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32: 270-279.
19. Park JE, Tan HS, Datta A, Lai RC, Zhang H, et al. (2010) Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes. Mol Cell Proteomics 9: 1085-1099.
20. Bussolino F, Mantovani A, Persico G (1997) Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22: 251-256.
21. Boomsma RA, Geenen DL (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7(4): e35685.
22. Gao X, Xu Z (2008) Mechanisms of action of angiogenin. Acta Biochim Biophys Sin 40: 619-624.
23. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, et al. (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Thorac Cardiovasc Surg 135: 799-808.
24. Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R (2011) Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6: 215-225.
25. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, et al. (2013) Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA110: 7312-7.
26. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, et al. (2013) Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 8(7): e68451.
27. Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441-464.
28. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal 2: 351-360.